The Emergence of Modern Cancer Immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1245/ASO.2005.01.904.pdf
Reference13 articles.
1. Durability of Complete Responses in Patients With Metastatic Cancer Treated With High-Dose Interleukin-2
2. Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer
3. Spanknebel K, Cheung KY, Stoutenburg J, et al. Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin 2. Ann Surg Oncol (in press)
4. Progress in human tumour immunology and immunotherapy
5. Cancer immunotherapy: moving beyond current vaccines
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment;Current Cancer Therapy Reviews;2020-02-06
2. Oncology Pharmacist’s Role and Impact on the Multidisciplinary Patient-Centre Practice of Oncology Clinic in Public Hospitals;Asia Pacific Journal of Health Management;2019-04-15
3. Cutaneous Cell- and Gene-Based Therapies for Inherited and Acquired Skin Disorders;Gene and Cell Therapy;2015-01-13
4. Modeling cancer immunotherapy: Assessing the effects of lymphocytes on cancer cell growth and motility;Physica A: Statistical Mechanics and its Applications;2013-05
5. Adaptive Immune Responses and HER2/neu-Positive Breast Cancer;Current Pathobiology Reports;2012-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3